Treatment with N-acetylcysteine does not alter blood glucose levels and the oxidative stress status in diabetic rats
Journal of Pharmaceutical Negative Results · 2013
DOI: 10.4103/0976-9234.116755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Negative Results, 2013. Verfasst von AndréValle de Bairros und 8 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Objectives
To verify the contribution of N‑acetylcysteine (NAC) as an antioxidantdrug in the therapy of diabetes, helping to reduce the deleterious effects resulting fromoxidative stress associated with the hyperglycemic state. Materials and Methods: Theanimals were divided into normal (saline, 25 mg/kg NAC, and 75 mg/kg NAC) anddiabetic rats (saline, 25 mg/kg NAC, and 75 mg/kg NAC) with five rats per group,and were treated for four weeks. Diabetes induction was performed by intraperitonealinjection of alloxan after fasting for 12 hours. Subsequently, glucose solution wasused to promote wear of the pancreatic beta cells. Blood parameters such as glucose,glycated hemoglobin, hepatic and renal biomarkers, and butyrylcholinesteraseactivity were determined by commercial kits. Catalase, glutathione peroxidase, andsuperoxide dismutase activities were measured using spectrophotometric techniques,while glutathione and malondialdehyde levels were determined by chromatographictechniques.
Results
NAC had no significant differences on glycemic, hepatic, renal,and oxidative stress biomarkers. Superoxide dismutase activity was significantlyhigher(P < 0.05) in diabetic rats treated with NAC compared to the diabetic saline group,while butyrylcholinesterase activity was significantly lower(P < 0.05) in the same groups.There was a negative correlation between superoxide dismutase and butyrylcholinesteraseactivities.
Conclusion
NAC supplementation did not re‑establish the antioxidant systemand consequently the deleterious effects of diabetes did not decrease. Diabetic groups thatreceived NAC demonstrated that superoxide dismutase activity was indirectly linked tothe levels of butyrylcholinesterase. More studies are necessary to investigate the action ofNAC on superoxide dismutase and butyrylcholinesterase activities in the diabetic state.
Zitieren
APA
Bairros, A. D., Freitas, F. D., Leal, M., Mazzanti, C., Moreira, A., Morsch, V., Ribeiro, G., Roehrs, M., & Tonello, R. (2013). Treatment with N-acetylcysteine does not alter blood glucose levels and the oxidative stress status in diabetic rats. Journal of Pharmaceutical Negative Results. https://doi.org/10.4103/0976-9234.116755
Vancouver
Bairros AD, Freitas FD, Leal M, Mazzanti C, Moreira A, Morsch V, et al. Treatment with N-acetylcysteine does not alter blood glucose levels and the oxidative stress status in diabetic rats. Journal of Pharmaceutical Negative Results. 2013. doi:10.4103/0976-9234.116755
BibTeX
@article{Bairros2013,
author = {Bairros, AndréValle de and Freitas, Fernando de and Leal, Mirna and Mazzanti, Cinthia and Moreira, AnaPaula and Morsch, VeraMaria and Ribeiro, Gianine and Roehrs, Miguel and Tonello, Raquel},
title = {Treatment with N-acetylcysteine does not alter blood glucose levels and the oxidative stress status in diabetic rats},
journal = {Journal of Pharmaceutical Negative Results},
year = {2013},
doi = {10.4103/0976-9234.116755}
}
EUVIMED